Addition of cognitive‐behaviour therapy for obsessive‐compulsive disorder patients non‐responding to fluoxetine
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Kampman M, Keijsers GPJ, Hoogduin CAL, Verbraak MJPM. Addition of cognitive‐behaviour therapy for obsessive‐compulsive disorder patients non‐responding to fluoxetine. Acta Psychiatr Scand 2002: 106: 314–319. © Blackwell Munksgaard 2002. Objective: Selective serotonin re‐uptake inhibitors (SSRIs) and cognitive behaviour therapy (CBT) have both proven to be effective in the treatment of obsessive compulsive disorder (OCD). It is generally recommended that adequate but unsuccessful SSRI treatment is supplemented with CBT, although only one empirical study was conducted to verify this recommendation. The present study examined the effects of supplemental CBT to continued fluoxetine treatment in OCD patients non‐responding to fluoxetine alone. Method: After 12 weeks of fluoxetine, 14 of 56 out‐patients had a reduction rate less than 25% on the Yale‐Brown Obsessive Compulsive Scale (Y‐BOCS) and were classified as non‐responders. They subsequently received 12 sessions CBT additional to the continued fluoxetine treatment. Results: The mean symptom reduction as rated by the Y‐BOCS, for the patients who completed both treatment phases, was 8.5% in the first phase and 41% in the second phase. Conclusion: Supplemental CBT for OCD patients, after initial, unsuccessful fluoxetine treatment is shown to be effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abramowitz, J. S. (1996) · Behavior Therapy · doi:10.1016/s0005-7894(96)80045-1 · Cited by 357 · cited 1×
“The best treatments currently available are the selective serotonin re-uptake inhibitors (SSRIs) like fluoxetine, fluvoxamine, sertraline or paroxetine (2, 3) and cognitive-behaviour therapy (CBT) comprising exposure and response prevention (2, 4).”
Backgroundde Haan, E., van Oppen, P., van Balkom, A. J. L. M., Spinhoven, P., Hoogduin, K. A. L., & van Dyck, R. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09929.x · Cited by 136
Kampman, M., Keijsers, G. P. J., Hoogduin, C. A. L., & Hendriks, G.-J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0904 · Cited by 87
Self-citation
Cited by
Foa, E. B., & McLean, C. P. (2016) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-021815-093533 · Cited by 360
Simpson, H. B., Foa, E. B., Liebowitz, M. R., Ledley, D. R., Huppert, J. D., Cahill, S., Vermes, D., Schmidt, A. B., Hembree, E., Franklin, M., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07091440 · Cited by 316
Simpson, H. B., Foa, E. B., Liebowitz, M. R., Huppert, J. D., Cahill, S., Maher, M. J., McLean, C. P., Bender, J., Marcus, S. M., Williams, M. T., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1932 · Cited by 248
Pharmacotherapy of Obsessive-compulsive Disorder and Obsessive-Compulsive Spectrum Disorders
Denys, D. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.02.013 · Cited by 213
Exposure and Response (Ritual) Prevention for Obsessive Compulsive Disorder: Therapist Guide
Foa, E. B., Yadin, E., & Lichner, T. K. (2012) · doi:10.1093/med:psych/9780195335286.001.0001 · Cited by 185
Metadata
- Authors
- Kampman, M., Keijsers, G. P. J., Hoogduin, C. A. L., & Verbraak, M. J. P. M.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2002-09-11
- Volume
- 106
- Issue
- 4
- Pages
- 314-319
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2172007294
- Cited by
- 93
- References
- 3
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Addition of cognitive‐behaviour therapy for obsessive‐compulsive disorder patients non‐responding to fluoxetine. https://app.cochat.ai/papers/10.1034/j.1600-0447.2002.01261.x
- The paper
- Kampman, M., Keijsers, G. P. J., Hoogduin, C. A. L., & Verbraak, M. J. P. M. (2002). Addition of cognitive‐behaviour therapy for obsessive‐compulsive disorder patients non‐responding to fluoxetine. Acta Psychiatrica Scandinavica. https://doi.org/10.1034/j.1600-0447.2002.01261.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.